Western blot analysis showed that the ERK1/2 and JNK inhibitors specifically inhibited CF-induced ERK1/2 autophosphorylation and c-jun (a direct downstream target phosphorylated by JNK) phosphorylation, respectively (Fig. 3B). Here, MAPK3 is linked to cystic fibrosis.